Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 42%
Buy 42%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Imax is viewed positively because its end-to-end ecosystem in capture, post-production, remastering, and premium exhibition enables filmmakers to create an experience that cannot be replicated at home, which is translating into outsized box office performance and stronger economics for the company and its partners. The recent success of The Odyssey underscores this advantage, with August box office of $322M, Q3-to-date box office of $579M, and $485M in IMAX GBO since late July, while IMAX’s 4170mm film locations generated $73M at an average of $1.8M per screen and more than a quarter of the film’s box office flowed through IMAX. The outlook is further supported by a diversified and expanding content slate, including local-language and alternative content, more than 120 pieces of content this year versus roughly 60 pre-COVID, a network of about 1,800 screens versus a 4,500 TAM, and upcoming titles such as Dune Part 3 in December and multiple 2027 releases, though China remains an important risk given its role as the company’s largest market.

Bears say

Imax is exposed to a highly concentrated and hit-driven business model, relying heavily on big-budget tentpole films and a narrow set of titles to drive outsized box office results, which makes its growth fragile if audience demand weakens or studios fail to deliver a steady volume of compelling content. Although the company generated $728M in box office from Memorial Day to Labor Day and $322M in August, those results were buoyed by exceptional performance from titles like The Odyssey, which produced $485M in IMAX Gross Box Office and accounted for more than a quarter of the film’s box office, underscoring how dependent the platform is on a few breakout releases rather than recurring, diversified demand. The outlook remains pressured by industry stress in exhibition, including the risk of weaker U.S. and international box office demand, and by the fact that IMAX’s North American revenue is heavily dependent on the top 20% of locations, making the business vulnerable if premium-format momentum fades or if theater operators face continued balance-sheet strain.

IMAX (IMAX) has been analyzed by 12 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 42% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 12 analysts, IMAX (IMAX) has a Buy consensus rating as of Oct 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $54.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $54.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.